Kuhne; Ronald

Patent Applications and Registrations

Patent applications and USPTO patent grants for Kuhne; Ronald.The latest application filed is for "polyproline mimetics of proline-derived module-15".

Company Profile

0.5.9

Kuhne; Ronald - Berlin DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Polyproline Mimetics Of Proline-derived Module-15 App 20210332050 - Kuhne; Ronald ; et al.	2021-10-28
Inhibitors for inhibiting tumor metastasis Grant 10,344,053 - Kuhne , et al. July 9, 2	2019-07-09
Inhibitors For Inhibiting Tumor Metastasis App 20170320910 - KUHNE; Ronald ; et al.	2017-11-09
Structural Mimetics Of Proline-rich Peptides And Use Thereof App 20150018269 - Kuhne; Ronald ; et al.	2015-01-15
Induction of alpha helix conformations in proteins and peptides Grant 8,815,932 - Schmalz , et al. August 26, 2	2014-08-26
Induction Of Alpha Helix Conformations In Proteins And Peptides App 20120172402 - Schmalz; Hans-Gunther ; et al.	2012-07-05
Tetrahydrocarbazole derivatives having improved biological action and improved solubility as ligands of G-protein coupled receptors (GPCPs) Grant 8,067,456 - Paulini , et al. November 29, 2	2011-11-29
Arylmethylen Substituted N-acyl-y-aminoalcohols App 20080287493 - Wortmann; Lars ; et al.	2008-11-20
Novel tetrahydrocarbazole derivatives having improved biological action and improved solubility as ligands of G-protein coupled receptors (GPCPs) App 20080280965 - Paulini; Klaus ; et al.	2008-11-13
Tetrahydrocarbazole derivatives having improved biological action and improved solubility as ligands of G-protein coupled receptors (GPCRs) Grant 7,375,127 - Paulini , et al. May 20, 2	2008-05-20
Novel tetrahydrocarbazole derivatives having improved biological action and improved solubility as ligands of G-protein coupled receptors (GPCRs) App 20060014818 - Paulini; Klaus ; et al.	2006-01-19
Quinoline, isoquinoline and phthalazine derivatives as antagonists of the gonadotropin-releasing hormone App 20030105328 - Strehlke, Peter ; et al.	2003-06-05

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.